ArticleFrontiers in neurology2025
Low radial and axial force stent retriever reduces symptomatic subarachnoid hemorrhage after mechanical thrombectomy for acute middle cerebral artery and medium vessel occlusion: a prospective pilot study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Evidence, strategies, and pathways for thrombectomy in medium vessel occlusion stroke: a systematic review.Frontiers in neurology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Subarachnoid hemorrhage (SAH) is a well-recognized complication after mechanical thrombectomy (MT) and may adversely affect clinical outcomes. SAH commonly results from vessel injury due to overextension or displacement during device retrieval. This risk is particularly concerning in smaller, tortuous vessels, such as in medium vessel occlusions (MeVO). This study evaluated whether a novel low radial and axial force stent retriever (Tron FX II) could reduce post-procedural SAH without compromising recanalization outcomes. Methods: The study comprised two components: (1) bench testing comparing radial/axial force and vessel displacement during retrieval between Tron FX II (hereafter Tron) and conventional devices; and (2) a prospective observational study of 197 consecutive MT patients. A combined technique was employed in all cases. Conventional stent retrievers were used until July 2023, after which Tron was used exclusively. Post-procedural SAH was assessed using dual-energy CT immediately after MT. The primary outcome was SAH incidence, with or without symptoms. Secondary outcomes included effective recanalization, first-pass rate, and 90-day functional outcomes. Results: Bench testing showed Tron exhibited the lowest radial/axial force and the smallest vessel deviation during retrieval. Clinically, Tron significantly reduced the incidence of post-procedural SAH (7.7% vs. 23.9%, Conclusion: The low radial and axial force stent retriever reduced post-procedural SAH while maintaining effective recanalization when combined with an aspiration catheter. These findings support its potential role as a safer option for MCAO and MeVO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.